Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population

Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population

During spring 2021, AZD1222 and BNT162b2 were used as prime and BNT162b2 as booster COVID-19 vaccines in Denmark. We obtained self-reported information on systemic reactogenicity day-by-day during two weeks for 2862 healthcare workers vaccinated with heterologous AZD1222 + BNT162b2 or homologous BNT...

Full description

Bibliographic Details
Main Authors: Sorosh Tabatabaeifar, Jesper M. Vestergaard, Else T. Würtz, Karoline K. Hansen, Kent J. Nielsen, Vivi Schlünssen, Henrik A. Kolstad
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Vaccine: X
Subjects:
COVID-19 vaccine
Systemic reactogenicity
Vaccine safety
Cohort study
Healthcare workers
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136223000219

Internet

http://www.sciencedirect.com/science/article/pii/S2590136223000219

Similar Items